High Content Screening Outsourcing Services Increasing Adoption of HCS for Primary Screening, and Emerging Economies in Asia and New Revenue Pockets for the High Content Screening Market
The HCS service market showcases a lucrative growth potential. This market includes services related to various phases of drug discovery such as target identification and target validation, primary screening, secondary screening and toxicity studies, and compound profiling among others. Among these services, primary screening represents the new revenue pocket for the HCS market. Across the globe, the adoption of high content screening for primary screening is increasing due to factors such as increased throughput, enhanced accuracy, and ease of use. A number of automated HCS instruments are available in the market. Moreover, market players are engaged in developing new automated HCS instruments with higher throughput, which will help the market grow further. Taking into consideration the growing demand for HCS products, various venture capitalists are now investing in this market. For instance, in November 2011, the Entrepreneurs Fund (U.K.) and Sham (France) invested $10 million...